Skip to content

AmplifEYE Colonoscopy vs Standard Colonoscopy

Use of AmplifEYE-assisted Colonoscopy Compared to Standard Colonoscopy in Polyp and Adenoma Detection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03814369
Enrollment
355
Registered
2019-01-24
Start date
2017-03-01
Completion date
2018-11-30
Last updated
2019-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Colon, Colonic Neoplasms, Colon Polyp, Serrated Polyp

Keywords

colonoscopy, adenoma detection rate, colorectal cancer screening, new technology

Brief summary

Colonoscopy screening is proven to reduce mortality rates for colorectal cancer, which relies on early detection and removal of colonic polyps. AmplifEYE is a FDA-approved device with a row of flexible detection arms attached to the tip of colonoscope which can separate colonic folds during scope withdrawal and is believed to improve polyp detection. Real-life clinical data on this relatively new device is lacking and this study aims to compare the adenoma and polyp detection rates in AmplifEYE-assisted colonoscopy versus standard colonoscopy.

Detailed description

This is a prospective, randomized controlled study. Patients admitted to Queen Elizabeth Hospital and Our Lady of Maryknoll Hospital for colonoscopy are randomly allocated 1:1 to receive either colonoscopy equipped with AmplifEYE (AC) or standard colonoscopy (SC). All study team members will have a prior run-in phase of performing at least 5 AmplifEYE colonoscopies before starting the study. The colonic polyp detection rate (PDR), adenoma detection rate (ADR), serrated polyp detection rate (SDR), caecal intubation time, colonoscope withdrawal time, procedure pain and any adverse events were analyzed in each group.

Interventions

DEVICEAmplifEYE

AmplifEYE colonoscopy

Sponsors

Our Lady of Maryknoll Hospital
CollaboratorOTHER
Queen Elizabeth Hospital, Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 50 to 79 years old * Scheduled for screening, surveillance or diagnostic colonoscopy

Exclusion criteria

* Colonic strictures * History of bowel surgery * Per-rectal bleeding within six weeks * Inflammatory bowel disease * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate1 daynumber of patients in whom at least one adenoma could be found

Secondary

MeasureTime frameDescription
Polyp detection rate1 daynumber of patients in whom at least one polyp could be found
Serrated polyp detection rate1 daynumber of patients in whom at least one serrated polyp could be found
caecal intubation rate1 daynumber of patients in whom caecal intubation is acheived
caecal intubation time1 daytime beginning with the insertion of the colonoscope until reaching the caecum

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026